P1.14-03 Phase II Trial of Amrubicin and Cisplatin Chemotherapy for Invasive Thymoma: WJOG5509L

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.08.905
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Malignant Invasive Thymoma With Chemotherapy Alone

MOJ Clinical & Medical Case Reports
2017English

Invasive Thymoma Treated Effectively by Preoperative Chemotherapy and Radiotherapy.

Japanese Journal of Lung Cancer
OncologyRespiratory MedicinePulmonary
1993English

Phase II Study of Second-Line Chemotherapy With Paclitaxel, Gemcitabine, and Cisplatin for Advanced Urothelial Carcinoma

Anticancer Research
MedicineCancer ResearchOncology
2020English

P1.14-04 Stereotactic Body Radiation Therapy for Pleural Recurrences of Thymoma

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Addition of Intraperitoneal Cisplatin and Etoposide to First-Line Chemotherapy for Advanced Ovarian Cancer: A Randomised, Phase 2 Trial

British Journal of Cancer
Cancer ResearchOncology
2018English

Mitomycin C and Vinorelbine for Second-Line Chemotherapy in NSCLC – A Phase II Trial

British Journal of Cancer
Cancer ResearchOncology
2007English

Cisplatin, Doxorubicin, and Cyclophosphamide Plus Thoracic Radiation Therapy for Limited-Stage Unresectable Thymoma: An Intergroup Trial.

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
1997English

Panitumumab Added to Docetaxel, Cisplatin and Fluoropyrimidine in Oesophagogastric Cancer: ATTAX3 Phase II Trial

British Journal of Cancer
Cancer ResearchOncology
2016English

Combination Chemotherapy With Irinotecan and Cisplatin for Large-Cell Neuroendocrine Carcinoma of the Lung: A Multicenter Phase II Study

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy